Summit Securities Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-268
Closed -$7K 598
2024
Q1
$7K Buy
+268
New +$7.63K ﹤0.01% 361
2023
Q3
Sell
-1
Closed 618
2023
Q2
$0 Hold
1
﹤0.01% 904
2023
Q1
$0 Buy
+1
New +$33 ﹤0.01% 860
2022
Q4
Sell
-100
Closed -$2K 1174
2022
Q3
$2K Hold
100
﹤0.01% 859
2022
Q2
$3K Hold
100
﹤0.01% 885
2022
Q1
$3K Sell
100
-21,100
-100% -$660K ﹤0.01% 1019
2021
Q4
$711K Buy
21,200
+2,700
+15% +$84.1K 0.03% 297
2021
Q3
$538K Sell
18,500
-4,350
-19% -$141K 0.04% 383
2021
Q2
$795K Buy
22,850
+1,150
+5% +$38.1K 0.07% 298
2021
Q1
$606K Buy
21,700
+10,900
+101% +$290K 0.07% 282
2020
Q4
$268K Buy
+10,800
New +$257K 0.02% 478

Other funds holding CC

Summit Securities Group's CC Position: Q2 2024 in Review

Summit Securities Group sold out of Chemours (CC) in Q2 2024, closing a stake of 268 shares — an estimated $7K sold.

Summit Securities Group first reported a position in CC in Q4 2020 and held it in 11 quarters. The position peaked at $795K in Q2 2021. 436 funds tracked by Wall St. Rank hold CC as of Q2 2024.

  • Summit Securities Group reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
  • Summit Securities Group sold 268 Chemours shares in Q2 2024, an estimated $7K.
  • Summit Securities Group first reported a position in Chemours in Q4 2020 and held it in 11 quarters.
  • Summit Securities Group's Chemours position peaked at $795K in Q2 2021.
  • 436 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Summit Securities Group's 13F filing for Q2 2024, filed 26 Jul 2024.